Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Christopher B. Fordyce, MD (he/him/his)

Associate Professor, UBC Cardiology
CANCARE
Division of Cardiology, University of British Columbia

Dr. Christopher Fordyce joined the Division of Cardiology at the University of British Columbia (UBC) in 2016 and is currently a Clinical Associate Professor. He is the Director of the Cardiac Intensive Care Unit at Vancouver General Hospital, Scientist at the UBC Centre for Advancing Health Outcomes, and Director of Site Based Research for the UBC Centre for Cardiovascular Innovation. Following medical school at McGill University, he trained in both Internal Medicine and Cardiology at UBC. He completed a clinical research fellowship in cardiovascular disease at the Duke Clinical Research Institute as well as subspecialty training in cardiac critical care at Duke University Hospital. His clinical and research interests lie predominately in acute cardiac conditions, including acute coronary syndrome and cardiac arrest, as well as chronic coronary disease and atrial fibrillation. He also completed the Program in Clinical Effectiveness at the Harvard School of Public Health, and a Master’s of Health Science in Clinical Research through the Duke School of Medicine. He was on the Primary Panel of the 2019 CCS STEMI Guidelines, was the Chair of 2020 American Heart Association Scientific Statement on Preventing Complications in the CICU, as well the Co-chair of the 2023 CCS Position Statement for Neuroprognostication following Cardiac Arrest. Dr. Fordyce is a recipient of the Michael Smith Foundation for Health Research Health Professional-Investigator Award. He has authored over 140 peer-reviewed manuscripts, many in high-impact journals such as Circulation, the Journal of the American College of Cardiology, JAMA Cardiology and the New England Journal of Medicine. He serves on the Editorial Board of the American Heart Journal. He has been selected to the Honour Roll for Clinical Teaching Excellence by the UBC Department of Medicine, and Best Clinical Mentor in the UBC Division of Cardiology on multiple occasions.

Disclosure(s): Amgen: Research Grant (Ongoing); Boehringer Ingelheim: Advisor (Ongoing); HLS Therapeutics: Speaker (Ongoing); New Amsterdam: Consultant (Ongoing); Novartis: Consultant (Ongoing), Research Grant (Ongoing); Novo Nordisk: Advisor, Speaker (Ongoing), Consultant (Ongoing), Global Expert Panel (Ongoing); Sanofi: Speaker (Ongoing)

Presentation(s):